These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice. Ninkina N; Tarasova TV; Chaprov KD; Roman AY; Kukharsky MS; Kolik LG; Ovchinnikov R; Ustyugov AA; Durnev AD; Buchman VL Neurobiol Aging; 2020 Jul; 91():76-87. PubMed ID: 32224067 [TBL] [Abstract][Full Text] [Related]
10. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254 [TBL] [Abstract][Full Text] [Related]
11. A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine. Brehm N; Bez F; Carlsson T; Kern B; Gispert S; Auburger G; Cenci MA Mol Neurobiol; 2015 Dec; 52(3):1152-1164. PubMed ID: 25307288 [TBL] [Abstract][Full Text] [Related]
12. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons. Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147 [TBL] [Abstract][Full Text] [Related]
13. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439 [TBL] [Abstract][Full Text] [Related]
14. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease. Alarcón-Arís D; Recasens A; Galofré M; Carballo-Carbajal I; Zacchi N; Ruiz-Bronchal E; Pavia-Collado R; Chica R; Ferrés-Coy A; Santos M; Revilla R; Montefeltro A; Fariñas I; Artigas F; Vila M; Bortolozzi A Mol Ther; 2018 Feb; 26(2):550-567. PubMed ID: 29273501 [TBL] [Abstract][Full Text] [Related]
15. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Nordströma U; Beauvais G; Ghosh A; Pulikkaparambil Sasidharan BC; Lundblad M; Fuchs J; Joshi RL; Lipton JW; Roholt A; Medicetty S; Feinstein TN; Steiner JA; Escobar Galvis ML; Prochiantz A; Brundin P Neurobiol Dis; 2015 Jan; 73():70-82. PubMed ID: 25281317 [TBL] [Abstract][Full Text] [Related]
16. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
17. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit. Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092 [TBL] [Abstract][Full Text] [Related]
18. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093 [TBL] [Abstract][Full Text] [Related]
19. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577 [TBL] [Abstract][Full Text] [Related]
20. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease. Ahlers-Dannen KE; Spicer MM; Fisher RA Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]